SCHEMBL30866165

SCHEMBL30866165

CC(C)(C)OC(=O)N1Cc2cn(-c3ccc([N+](=O)[O-])cc3)nc2C1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.57
ALDH1A1 P00352 3/20 0.57
LMNA P02545 2/20 0.57
MAPK1 P28482 2/20 0.41
PDK2 Q15119 1/20 0.41
HDAC1 Q13547 1/20 0.40
ESR2 Q92731 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HTT P42858 1/20 0.39
GPR119 Q8TDV5 2/20 0.39
NR1H2 P55055 1/20 0.38
SLC6A9 P48067 3/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
KCNH2 Q12809 1/20 0.38
SLC34A1 Q06495 1/20 0.38
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17202429 0.84 GRM5 (0.49) PDK2HDAC1ESR2GPR119SLC6A9
SCHEMBL23015352 0.84 HDAC1 (0.45) MAPK1PDK2HDAC1ESR2GPR119
SCHEMBL29240214 0.83 MAPT (0.43) MAPTLMNAPDK2SMN1; SMN2HTT
SCHEMBL28967185 0.82 PDK2 (0.42) MAPK1PDK2HDAC1ESR2GPR119
SCHEMBL21525539 0.81 PDK2 (0.44) MAPTPDK2HDAC1ESR2GPR119
SCHEMBL18883091 0.81 PDK2 (0.41) MAPK1PDK2HDAC1ESR2SMN1; SMN2
SCHEMBL23015254 0.79 USP30 (0.44) MAPTALDH1A1LMNAMAPK1PDK2
SCHEMBL30834648 0.79 GPR119 (0.44) MAPTALDH1A1LMNAPDK2HDAC1
SCHEMBL30866131 0.78 LMNA (0.57) MAPTALDH1A1LMNAPDK2ESR2
SCHEMBL30899238 0.77 SLC34A1 (0.45) PDK2HDAC1ESR2NR1H2SLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117917415-A Substituted heteropolycyclic compound, preparation method and application thereof 映恩生物制药(苏州)有限公司 2024-04-23 CN disclosed